Harrington Investments’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,657
| Closed | -$224K | – | 84 |
|
|
2026
Q1 | $224K | Hold |
4,657
| – | – | 0.12% | 83 |
|
|
2025
Q4 | $226K | Sell |
4,657
-95
| -2% | -$4.71K | 0.11% | 84 |
|
|
2025
Q3 | $224K | Sell |
4,752
-250
| -5% | -$12.1K | 0.11% | 84 |
|
|
2025
Q2 | $242K | Hold |
5,002
| – | – | 0.13% | 79 |
|
|
2025
Q1 | $277K | Sell |
5,002
-85
| -2% | -$4.6K | 0.16% | 79 |
|
|
2024
Q4 | $245K | Sell |
5,087
-89
| -2% | -$4.53K | 0.13% | 79 |
|
|
2024
Q3 | $298K | Sell |
5,176
-143
| -3% | -$7.72K | 0.16% | 70 |
|
|
2024
Q2 | $258K | Hold |
5,319
| – | – | 0.15% | 72 |
|
|
2024
Q1 | $259K | Sell |
5,319
-484
| -8% | -$23.6K | 0.15% | 72 |
|
|
2023
Q4 | $289K | Hold |
5,803
| – | – | 0.18% | 71 |
|
|
2023
Q3 | $311K | Hold |
5,803
| – | – | 0.21% | 64 |
|
|
2023
Q2 | $313K | Sell |
5,803
-190
| -3% | -$10.2K | 0.21% | 66 |
|
|
2023
Q1 | $326K | Sell |
5,993
-100
| -2% | -$4.86K | 0.23% | 65 |
|
|
2022
Q4 | $295K | Hold |
6,093
| – | – | 0.21% | 64 |
|
|
2022
Q3 | $232K | Buy |
6,093
+168
| +3% | +$7.49K | 0.18% | 67 |
|
|
2022
Q2 | $296K | Sell |
5,925
-76
| -1% | -$4.03K | 0.22% | 65 |
|
|
2022
Q1 | $308K | Sell |
6,001
-235
| -4% | -$12.1K | 0.18% | 69 |
|
|
2021
Q4 | $312K | Buy |
6,236
+519
| +9% | +$25.7K | 0.17% | 73 |
|
|
2021
Q3 | $276K | Sell |
5,717
-880
| -13% | -$44.7K | 0.16% | 77 |
|
|
2021
Q2 | $347K | Sell |
6,597
-221
| -3% | -$11.5K | 0.21% | 70 |
|
|
2021
Q1 | $337K | Buy |
6,818
+648
| +11% | +$31.1K | 0.21% | 71 |
|
|
2020
Q4 | $300K | Buy |
6,170
+136
| +2% | +$6.71K | 0.2% | 69 |
|
|
2020
Q3 | $303K | Sell |
6,034
-1,050
| -15% | -$54.1K | 0.21% | 66 |
|
|
2020
Q2 | $362K | Hold |
7,084
| – | – | 0.28% | 65 |
|
|
2020
Q1 | $310K | Hold |
7,084
| – | – | 0.29% | 66 |
|
|
2019
Q4 | $356K | Sell |
7,084
-450
| -6% | -$21.1K | 0.28% | 69 |
|
|
2019
Q3 | $349K | Sell |
7,534
-330
| -4% | -$14.2K | 0.29% | 70 |
|
|
2019
Q2 | $340K | Buy |
7,864
+1,230
| +19% | +$52.3K | 0.28% | 70 |
|
|
2019
Q1 | $294K | Sell |
6,634
-100
| -1% | -$4.28K | 0.25% | 70 |
|
|
2018
Q4 | $292K | Sell |
6,734
-1,086
| -14% | -$47.9K | 0.28% | 67 |
|
|
2018
Q3 | $349K | Hold |
7,820
| – | – | 0.28% | 65 |
|
|
2018
Q2 | $313K | Sell |
7,820
-975
| -11% | -$38.4K | 0.26% | 68 |
|
|
2018
Q1 | $353K | Buy |
8,795
+2,296
| +35% | +$95.5K | 0.29% | 65 |
|
|
2017
Q4 | $279K | Buy |
6,499
+250
| +4% | +$11.5K | 0.23% | 74 |
|
|
2017
Q3 | $311K | Buy |
+6,249
| New | +$302K | 0.3% | 61 |
|
Other funds holding SNY
MIP
DC
BCM
FRM
EIP
TWC
Harrington Investments's SNY Position: Q2 2026 in Review
Harrington Investments sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,657 shares — an estimated $224K sold.
Harrington Investments first reported a position in SNY in Q3 2017 and held it in 35 quarters. The position peaked at $362K in Q2 2020. 277 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Harrington Investments reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
- Harrington Investments sold 4,657 Sanofi shares in Q2 2026, an estimated $224K.
- Harrington Investments first reported a position in Sanofi in Q3 2017 and held it in 35 quarters.
- Harrington Investments's Sanofi position peaked at $362K in Q2 2020.
- 277 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Harrington Investments's 13F filing for Q2 2026, filed 23 Jul 2026.